UK jobs data released yesterday was grim: more than 250000 jobs have been lost

Alliance News: “The UK jobs data released yesterday was grim: more than 250,000 jobs have been lost since October’s budget announcement.

The latest UK jobs data was released yesterday and it showed that more than 250,000 jobs have been lost since October’s budget announcement.

The latest UK jobs data was released yesterday and it showed that more than 250,000 jobs have been lost since October’s budget announcement.

The employment market in the UK is usually strong, however, higher taxes are weighing on employment and sustaining inflationary pressure, complicating the Bank of England’s policy outlook.

The employment market in the UK is usually strong, however, higher taxes are weighing on employment and sustaining inflationary pressure, complicating the Bank of England’s policy outlook.

Despite this, markets are increasingly pricing in rate cuts amid signs of further weakness.

Despite this, markets are increasingly pricing in rate cuts amid signs of further weakness.

The socialist government has perfectly delivered the socialist policy of impoverishing the nation, so more people are forced to vote Labour for welfare. In the latest example, another 250,000 who have lost their jobs. This is a deliberate policy / action, not incompetence.

Solvonis Therapeutics (SVNS) has announced the initiation of an artificial intelligence (“AI”) supported drug discovery programme focused on its proprietary central nervous system (“CNS”) compound library.

Solvonis Therapeutics (SVNS) has announced the initiation of an artificial intelligence (“AI”) supported drug discovery programme focused on its proprietary central nervous system (“CNS”) compound library.

The programme will initially prioritise indications in depression and stimulant use disorders.

SVNS is already showing with its newsflow to be on the money as far as its technology, as well as being focused on the disorders with the greatest need. The valuation of the company at still only £13m is very much an entry level opportunity.

Valereum (AQSE: VLRM) announced that Nick Cowan will be stepping down as CEO, with immediate effect, following the unsuccessful completion of the DMC deal. A total of 10,000,000 warrants previously allocated to Nick Cowan have been cancelled. VLRM said “Valereum is now heading for the global stage, and the proposed Board changes emphasise the expertise and experience required to take the next step.”

It was a bit harsh perhaps to cancel Cowan’s warrants. As far as VLRM being on the global stage, the recent past the decline from 30p to 4.2p as DMC ran off (remember Walk This Way), will take some getting back from.

Celadon Pharmaceuticals (CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines, announces that further to the 6 June 2025 announcement, it has entered into a new £0.5 million (gross) one year unsecured credit facility with a European based high net worth individual lender (the “Lender”) (the “New Facility”) and has received funds totalling £0.5 million.

After persistently baiting the company over the past couple of months, the bears will be upset that CEL has managed to dodge the Grim Reaper for at least a temporary reprieve.

The boards of WSP Global, WSP UK and Ricardo (RCDO) announced that they have reached agreement on the terms of a recommended final* cash acquisition pursuant to which WSP UK, or another wholly-owned subsidiary of WSP Global, will acquire the entire issued and to be issued share capital of Ricardo other than the Ricardo.

Shares of RCDO have been rising like a homesick angel in the past few sessions, suggesting that everyone and their mother new this deal was on its way. And for journalists who do not understand the stock market, it is good news when a company gets taken over, that is what being listed is for.

Hydrogen Utopia International (HUI), a company specialising in turning non-recyclable mixed waste plastic into hydrogen and other carbon-free fuels, new materials or distributed renewable heat, announced that, further to the announcement of 6 June 2025, it has raised gross proceeds of £250,000 at the price of £0.0175 per share under existing unspent share authorities.

A timely raise for HUI in the wake of last week’s MENA waste-hydrogen announcement breakthrough. One would consider the company is now funded to execute the rollout. Note the shares are already trading well above the placing price.

Premier African Minerals (PREM) announced a subscription today to raise £1,575 million before expenses at an issue price of 0.012 pence per new ordinary share (“Issue Price”) for the Zulu Lithium and Tantalum Project. In addition, the Company has settled US$1.1 million (equivalent to £0.740 million) worth of contractor’s invoices of Zulu through the issue of 6,174,166,667 new ordinary shares in the Company at the Issue Price.

Like Banquo’s ghost x 2, we have both George Roach and a placing, just in case anyone thought it was the end of an era. Apparently, not quite.

Helium One Global (HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development project in Colorado, USA, provides the following update on the current status of the award of the Mining Licence in Tanzania. Negotiation of Regulatory Framework Agreements being finalised. Government free carried interest agreed